Rani Therapeutics Stock

ranitherapeutics.comHealthcare / BioTech & PharmaFounded: 2012Funding to Date: $116.33MM

Rani Therapeutics is the developer of a platform for the oral delivery of biologic drugs.

Register To Buy and Sell Shares

For more details on financing and valuation for Rani Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Rani Therapeutics’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Rani Therapeutics.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

Rani Therapeutics investors also invested in these private companies


Management Team

Svai Sanford
Chief Financial Officer
Talat Imran
Founder & Chief Executive Officer
Mir Hashim Ph.D
Chief Scientific Officer & Board Member

Board Members

Andrew Farquharson
InCube Ventures
Blake Byers Ph.D
Updated on: Apr 17, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.